Sitagliptin for Prevention of aGVHD After Alternative Donor Transplatation
Conditions: Acute-graft-versus-host Disease; Allogeneic Hematopoietic Stem Cell Transplantation Interventions: Drug: Sitagliptin + Standard Prophylaxis; Drug: Standard Prophylaxis Sponsors: The First Affiliated Hospital of Soochow University; The First Affiliated Hospital with Nanjing Medical University; The Second People's Hospital of Huai'an; The First People's Hospital of Changzhou; Xinqiao Hospital of Chongqing Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2021 Category: Research Source Type: clinical trials
Replication of the GRADE Diabetes Trial in Healthcare Claims Data
Condition: Diabetes Interventions: Drug: Sitagliptin; Drug: Glimepiride Sponsor: Brigham and Women's Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 29, 2021 Category: Research Source Type: clinical trials
